Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 1
2001 2
2002 3
2003 1
2004 4
2005 2
2006 7
2007 3
2008 1
2009 2
2010 1
2011 3
2012 6
2013 3
2014 5
2015 3
2016 2
2017 2
2018 3
2019 3
2020 4
2021 6
2022 4
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure.
Schönborn L, Esteban O, Wesche J, Dobosz P, Broto M, Puig SR, Fuhrmann J, Torres R, Serra J, Llevadot R, Palicio M, Wang JJ, Gordon TP, Lindhoff-Last E, Hoffmann T, Alberio L, Langer F, Boehme C, Biguzzi E, Grosse L, Endres M, Liman T, Thiele T, Warkentin TE, Greinacher A. Schönborn L, et al. Among authors: biguzzi e. Blood. 2023 Dec 28;142(26):2305-2314. doi: 10.1182/blood.2023022136. Blood. 2023. PMID: 37883798 Free PMC article.
Advances in the treatment of bleeding disorders.
Peyvandi F, Garagiola I, Biguzzi E. Peyvandi F, et al. Among authors: biguzzi e. J Thromb Haemost. 2016 Nov;14(11):2095-2106. doi: 10.1111/jth.13491. Epub 2016 Oct 19. J Thromb Haemost. 2016. PMID: 27590165 Free article. Review.
von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.
Pagliari MT, Budde U, Baronciani L, Eshghi P, Ahmadinejad M, Badiee Z, Baghaipour MR, Benítez Hidalgo O, Biguzzi E, Bodó I, Castaman G, Goudemand J, Karimi M, Keikhaei B, Lassila R, Leebeek FWG, Lopez Fernandez MF, Marino R, Oldenburg J, Peake I, Santoro C, Schneppenheim R, Tiede A, Toogeh G, Tosetto A, Trossaert M, Yadegari H, Zetterberg EMK, Mannucci PM, Federici AB, Eikenboom J, Peyvandi F. Pagliari MT, et al. Among authors: biguzzi e. J Thromb Haemost. 2023 Apr;21(4):787-799. doi: 10.1016/j.jtha.2023.01.001. Epub 2023 Jan 11. J Thromb Haemost. 2023. PMID: 36792472 Free article.
Management of rare acquired bleeding disorders.
Menegatti M, Biguzzi E, Peyvandi F. Menegatti M, et al. Among authors: biguzzi e. Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):80-87. doi: 10.1182/hematology.2019000066. Hematology Am Soc Hematol Educ Program. 2019. PMID: 31808848 Free PMC article.
Real-world data on emicizumab prophylaxis in the Milan cohort.
Arcudi S, Gualtierotti R, Marino S, Nicolò G, Biguzzi E, Ciavarella A, Boscarino M, Siboni SM, Schiavone L, Novembrino C, Valsecchi C, Peyvandi F. Arcudi S, et al. Among authors: biguzzi e. Haemophilia. 2022 Sep;28(5):e141-e144. doi: 10.1111/hae.14630. Epub 2022 Jul 19. Haemophilia. 2022. PMID: 35853212 No abstract available.
Genetic determinants of enhanced von Willebrand factor clearance from plasma.
Seidizadeh O, Baronciani L, Pagliari MT, Cozzi G, Colpani P, Cairo A, Siboni SM, Biguzzi E, Peyvandi F. Seidizadeh O, et al. Among authors: biguzzi e. J Thromb Haemost. 2023 May;21(5):1112-1122. doi: 10.1016/j.jtha.2023.01.012. Epub 2023 Jan 20. J Thromb Haemost. 2023. PMID: 36754679 Free article.
66 results